1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Clinical Research Training Fellowships are $130,000 awards from the American Academy of Neurology (AAN) that fund early career neurologists conducting clinical research.
The program includes multiple disease-specific tracks — including ALS, Parkinson's disease, epilepsy, Alzheimer's disease, stroke, multiple sclerosis, and peripheral neuropathy — each co-funded by specialized foundations in partnership with the American Brain Foundation. Eligible applicants are AAN members who are residents or fellows at academic institutions. Funding begins July 1 following selection.
The 2026 application deadline is September 1, 2026, with recipients notified in January.
Get alerted about grants like this
Save a search for “American Academy of Neurology (AAN)” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Clinical Research Training Scholarship | AAN Explore the latest content from across our publications Email or 6-digit member ID Password We’re experiencing unusually high levels of traffic. Thank you for your patience. The 2026 application period is closed.
Recipients will be notified in January 2026 with funding beginning July 1, 2026.
Clinical Research Training Scholarship Funded by the American Academy of Neurology * Detailed RFA listed at the bottom of this page Clinical Research Training Scholarship in ALS Funded by The ALS Association and the American Brain Foundation In collaboration with the American Academy of Neurology Clinical Research Training Scholarship in FTD Funded by Holloway Family Fund of The Association for Frontotemporal Degeneration and the American Brain Foundation In collaboration with the American Academy of Neurology Clinical Research Training Scholarship in Lewy Body Diseases Funded by the Alzheimer's Association and the American Brain Foundation In collaboration with the American Academy of Neurology Clinical Research Training Scholarship in Mal de Debarquement Syndrome and Central Vestibular Neurological Disorders Funded by the MdDs Balance Disorder Foundation and the American Brain Foundation In collaboration with the American Academy of Neurology Clinical Research Training Scholarship in Parkinson's Disease Funded by the Parkinson's Foundation and the American Brain Foundation In collaboration with the American Academy of Neurology Clinical Research Training Scholarship in Peripheral Neuropathy Funded by the Foundation for Peripheral Neuropathy and the American Brain Foundation In collaboration with the American Academy of Neurology Jeanne C.
Mayer Multiple Sclerosis Research Award Funded by the Herbert R. Mayer and Jeanne C. Mayer Foundation through the American Brain Foundation In collaboration with the American Academy of Neurology Lawrence M.
Brass, MD, Clinical Research Training Scholarship in Stroke Funded by the American Heart Association and the American Brain Foundation In collaboration with the American Academy of Neurology McKnight Clinical Translational Research Scholarship in Cognitive Aging and Age-Related Memory Loss Funded by the McKnight Brain Research Foundation through the American Brain Foundation and the American Academy of Neurology Robert Katzman, MD, Clinical Research Training Scholarship in Alzheimer's and Dementia Research Funded by the Alzheimer's Association and the American Brain Foundation In collaboration with the American Academy of Neurology Susan S.
Spencer, MD, Clinical Research Training Scholarship in Epilepsy Funded by the American Epilepsy Society, Epilepsy Foundation, and the American Brain Foundation, in collaboration with the American Academy of Neurology Clinical Research Training Scholarship Funded by the American Academy of Neurology The application period is closed.
This award aims to recognize the importance of good clinical research and to encourage early career investigators in clinical studies. This award will consist of a commitment of $65,000 per year for two years, plus a $10,000 per year stipend to support education and research-related costs for a total of $150,000.
Supplementation of the award with other grants is permissible, but to be eligible to apply for this award, the other grant source(s) cannot exceed $75,000 annually. The American Academy of Neurology is firmly committed to embracing the diversity among our members, applicants, and reviewers and affirms the importance of equity and inclusiveness within the AAN research program.
June 2, 2025: Applications open September 9, 2025: Application deadline—Note that this is the deadline for all documents, including those from the mentor and chair.
January 2026: Notification of recipients July 1, 2026: Funding begins For the purpose of this scholarship, research is defined as “patient-oriented research conducted with human subjects, or translational research specifically designed to develop treatments or enhance diagnosis of neurological disease.
These areas of research include epidemiologic or behavioral studies, clinical trials, studies of disease mechanisms, the development of new technologies, and health services and outcomes research. ” Disease-related studies not directly involving humans or human tissue are also encouraged if the primary goal is the development of therapies, diagnostic tests, or other tools to prevent or mitigate neurological diseases.
Recipient must be an AAN member interested in an academic career in neurological research with an MD, PhD, or equivalent doctoral-level clinical degree who has completed clinical residency or PhD no more than 5 years prior to the beginning of this award (July 1, 2026). If you have completed both residency and a PhD, your eligibility is based on when you completed residency.
If you completed a fellowship of any kind after residency, your eligibility is still based on the date you finished residency. Applicants at accredited US and international institutions are eligible. Applications are evaluated by reviewers based on the following criteria: Quality and originality of the research plan.
Applicant’s ability and promise as a clinician-scientist based on prior record of achievement and career plan, and NIH Biosketch. Quality and nature of the training to be provided, and the mentor-specific, departmental, and institutional training environment. Innovation of the research plan approach.
Project significance: the ability to progress the field or solve an important problem. A successful application should include the following: Well-developed hypothesis : The hypothesis is testable and presented in clear language. Detailed statistical plan : Statistical methods are well-designed and detailed.
Strong mentorship : There is clear demonstration of strong mentorship to support the project. Feasible primary outcomes : Each aim is feasible, focused, and logical. Innovation : Project concept is original, novel, and will advance the applicant’s long-term career goals.
Well-defined training plan : There is a clear and gap-based career development plan. Required attachments for applications PDF of three-page research plan, including brief statements of aims, background, contemplated approaches to methodology, and any supporting preliminary data/figures. References do not count toward the page limit.
The research plan should be written by the applicant and should represent their original work. However, the applicant is expected and encouraged to develop this plan based on discussion with the proposed mentor. It is appropriate, but not required, for the proposed work to be specifically related to the mentor’s ongoing research.
PDF of applicant’s NIH Biosketch. See the most recent NIH Biosketch template. Once the above information is fully completed and submitted by the applicant: The chair will receive an email with a link asking them to check a box confirming that the applicant’s clinical service responsibilities will be restricted to no more than 30 percent of your time and include a list of the applicant’s non-research-related service.
The chair will NOT be asked to submit a letter. The mentor will receive an email with a link to submit a letter of reference detailing their support of and commitment to the applicant and the proposed research and training plan.
The letter should be 1,000 words or less and specifically indicate the mentor’s role in the development and preparation of the applicant’s research plan and should include: How the proposed research fits into the mentor’s research program. Expertise and experience in the area of research proposed, and the nature of the mentor’s proposed time commitment to the supervision and training of the applicant.
Mentor’s prior experience in the supervision, training, and successful mentoring of clinician-scientists. Potential for applicant’s future research career and comparison of applicant among other trainees. Institution's commitment to 70 percent protected research time.
The mentor will also be required to upload an NIH Biosketch. View our frequently asked questions to learn more. For additional information or inquiries, please contact Ashley Nielsen, please contact Ashley Nielsen at research@aan.
com or (612) 928-6378 .
Based on current listing details, eligibility includes: AAN members who are residents or fellows at academic institutions. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates $130,000 Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is September 1, 2026. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
The NEI uses this U44 Notice of Funding Opportunity to support SBIR grant applications from small business concerns (SBCs) that propose to implement investigator-initiated, early-stage clinical trials with greater than minimal risk and typically are Phase I or II trials. The risk level of the U44 trial requires appropriate performance oversight and safety monitoring. For purposes of this NOFO, the proposed study must be intended to evaluate interventions aimed at screening, diagnosing, preventing, or treating vision disorders.Applicants are strongly advised to consult with NEI program staff prior to submitting an application with human subjects to determine the appropriate funding opportunity. Funding Opportunity Number: PAR-24-066. Assistance Listing: 93.867. Funding Instrument: CA. Category: HL.
Individual Investigator Research Awards for Clinical Trials (IIRACT) is a grant from the Cancer Prevention and Research Institute of Texas (CPRIT) that funds clinical trials research aimed at preventing and curing cancer in Texas. The program supports Texas-based entities conducting clinical trials across cancer types, with applications accepted through May 20, 2026 (RRCTA mechanism) and with an April 28, 2026 deadline for individual investigator awards. Eligible applicants include nonprofit institutions and private companies based in Texas. CPRIT now supports ORCID IDs in applicant profiles to streamline the application process.